NO982754L - Fosfolipidderivater av fosfonokarboksylsyrer, fremstilling av slike derivater og anvendelse av derivatene som antivirusmedikamenter - Google Patents

Fosfolipidderivater av fosfonokarboksylsyrer, fremstilling av slike derivater og anvendelse av derivatene som antivirusmedikamenter

Info

Publication number
NO982754L
NO982754L NO982754A NO982754A NO982754L NO 982754 L NO982754 L NO 982754L NO 982754 A NO982754 A NO 982754A NO 982754 A NO982754 A NO 982754A NO 982754 L NO982754 L NO 982754L
Authority
NO
Norway
Prior art keywords
derivatives
preparation
phospholipid
antiviral drugs
phosphonocarboxylic acids
Prior art date
Application number
NO982754A
Other languages
English (en)
Norwegian (no)
Other versions
NO982754D0 (no
Inventor
Harald Zilch
Dieter Herrmann
Hans-Georg Opitz
Gerd Zimmermann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1995147023 external-priority patent/DE19547023A1/de
Priority claimed from DE1996143416 external-priority patent/DE19643416A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO982754D0 publication Critical patent/NO982754D0/no
Publication of NO982754L publication Critical patent/NO982754L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4062—Esters of acids containing the structure -C(=X)-P(=X)(XR)2 or NC-P(=X)(XR)2, (X = O, S, Se)
    • C07F9/4065—Esters of acids containing the structure -C(=X)-P(=X)(XR)2, (X = O, S, Se)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075—Esters with hydroxyalkyl compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO982754A 1995-12-15 1998-06-15 Fosfolipidderivater av fosfonokarboksylsyrer, fremstilling av slike derivater og anvendelse av derivatene som antivirusmedikamenter NO982754L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1995147023 DE19547023A1 (de) 1995-12-15 1995-12-15 Neue Phospholipid-Derivate von Phosphonocarbonsäuren, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel
DE1996143416 DE19643416A1 (de) 1996-10-22 1996-10-22 Neue Phospholipid-Derivate von Phosphonocarbonsäuren, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel
PCT/EP1996/005647 WO1997022613A1 (fr) 1995-12-15 1996-12-16 Derives phospholipidiques d'acides phosphonocarboxyliques, leur production et leur utilisation comme medicaments antiviraux

Publications (2)

Publication Number Publication Date
NO982754D0 NO982754D0 (no) 1998-06-15
NO982754L true NO982754L (no) 1998-08-13

Family

ID=26021319

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982754A NO982754L (no) 1995-12-15 1998-06-15 Fosfolipidderivater av fosfonokarboksylsyrer, fremstilling av slike derivater og anvendelse av derivatene som antivirusmedikamenter

Country Status (23)

Country Link
US (1) US6136797A (fr)
EP (1) EP0868425B1 (fr)
JP (1) JP2000515113A (fr)
KR (1) KR20000064374A (fr)
CN (1) CN1085672C (fr)
AR (1) AR005089A1 (fr)
AT (1) ATE278698T1 (fr)
AU (1) AU714236B2 (fr)
BR (1) BR9612133A (fr)
CA (1) CA2240366A1 (fr)
CZ (1) CZ291823B6 (fr)
DE (1) DE59611111D1 (fr)
ES (1) ES2230574T3 (fr)
HU (1) HUP0001534A3 (fr)
IL (1) IL124790A (fr)
NO (1) NO982754L (fr)
NZ (1) NZ325259A (fr)
PL (1) PL186402B1 (fr)
RU (1) RU2166508C2 (fr)
SK (1) SK75698A3 (fr)
TR (1) TR199801082T2 (fr)
TW (1) TW343975B (fr)
WO (1) WO1997022613A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19547022A1 (de) * 1995-12-15 1997-06-19 Boehringer Mannheim Gmbh Kovalente Lipid-Phosphonocarbonsäure-Konjugate, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel
US6835721B2 (en) * 1999-02-01 2004-12-28 Eisai Co., Ltd. Immunomodulatory compounds and methods of use thereof
US7915238B2 (en) * 1999-02-01 2011-03-29 Eisai R & D Management Co., Ltd. Immunomodulatory compounds and methods of use thereof
US6551600B2 (en) * 1999-02-01 2003-04-22 Eisai Co., Ltd. Immunological adjuvant compounds compositions and methods of use thereof
US20040006242A1 (en) 1999-02-01 2004-01-08 Hawkins Lynn D. Immunomodulatory compounds and method of use thereof
US6818057B2 (en) 1999-03-02 2004-11-16 Construction Research & Technology Gmbh Retarder for calcium sulfoaluminate cements
RU2265439C2 (ru) * 2000-01-04 2005-12-10 Де Риджентс Ов Де Юниверсити Ов Калифорния Лечение инфекции вируса иммунодефицита человека с лекарственной устойчивостью
RU2240792C2 (ru) * 2002-07-30 2004-11-27 Государственное учреждение Научно-исследовательский институт вирусологии им. Д.И. Ивановского РАМН Комбинации на основе нетропсина или его бис-производного, обладающие антигерпетической активностью
US20040172288A1 (en) * 2003-02-27 2004-09-02 Korn Lawrence D. Method for disseminating medical alert information
US20070292418A1 (en) * 2005-04-26 2007-12-20 Eisai Co., Ltd. Compositions and methods for immunotherapy
CN103285392A (zh) 2005-04-26 2013-09-11 卫材R&D管理株式会社 用于癌症免疫疗法的组合物和其用途
EP2826370A3 (fr) * 2008-11-06 2015-04-08 Vascular Biogenics Ltd. Composés lipidiques oxydés et leurs utilisations
EP2876094A1 (fr) 2014-04-03 2015-05-27 Basf Se Ciment et composition de liant à base de sulfate de calcium
KR101658048B1 (ko) * 2014-06-25 2016-09-20 한국생명공학연구원 포스파티딜콜린 합성경로 관여 물질을 포함하는 항바이러스용 조성물
WO2020006050A1 (fr) 2018-06-26 2020-01-02 Tsrl, Inc. Promédicaments métaboliquement stables

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050327B1 (fr) * 1980-10-21 1984-06-20 Roche Diagnostics GmbH Phospholipides contenant du soufre, leur procédé de préparation et médicaments contenant ces composés
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
DE3929217A1 (de) * 1989-09-02 1991-03-07 Boehringer Mannheim Gmbh Verwendung von phospholipid-derivaten als antivirale arzneimittel und neue phospholipide
DE4026265A1 (de) * 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
DE19547022A1 (de) * 1995-12-15 1997-06-19 Boehringer Mannheim Gmbh Kovalente Lipid-Phosphonocarbonsäure-Konjugate, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel

Also Published As

Publication number Publication date
RU2166508C2 (ru) 2001-05-10
CN1209133A (zh) 1999-02-24
CZ181098A3 (cs) 1998-10-14
BR9612133A (pt) 1999-07-13
CA2240366A1 (fr) 1997-06-26
IL124790A (en) 2002-04-21
HUP0001534A3 (en) 2002-08-28
WO1997022613A1 (fr) 1997-06-26
NO982754D0 (no) 1998-06-15
PL327173A1 (en) 1998-11-23
AR005089A1 (es) 1999-04-14
AU714236B2 (en) 1999-12-23
ES2230574T3 (es) 2005-05-01
ATE278698T1 (de) 2004-10-15
TR199801082T2 (xx) 1998-09-21
KR20000064374A (ko) 2000-11-06
PL186402B1 (pl) 2004-01-30
EP0868425A1 (fr) 1998-10-07
AU1373097A (en) 1997-07-14
TW343975B (en) 1998-11-01
IL124790A0 (en) 1999-01-26
DE59611111D1 (de) 2004-11-11
CZ291823B6 (cs) 2003-06-18
SK75698A3 (en) 1999-03-12
CN1085672C (zh) 2002-05-29
JP2000515113A (ja) 2000-11-14
NZ325259A (en) 2000-01-28
EP0868425B1 (fr) 2004-10-06
US6136797A (en) 2000-10-24
HUP0001534A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
EP0948341A4 (fr) Derives de medicaments phospholipidiques
AR027162A1 (es) Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen
NO20021111D0 (no) Anvendelse av 5-O-deoaminyl-6-O-metylerytronolid A-derivater for fremstilling av biologisk aktive produkter
FI925633L (fi) Foerfarande foer framstaellning av en farmaceutisk sammansaettning som selektivt saenker lipidnivaon i blodet
NO981008D0 (no) Farmasöytisk formulering
NO892936D0 (no) Fremgangsmaate for fremstilling av furanderivater.
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
NO982754L (no) Fosfolipidderivater av fosfonokarboksylsyrer, fremstilling av slike derivater og anvendelse av derivatene som antivirusmedikamenter
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
FI960160A7 (fi) Imidatso/1,2-a/pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO891588D0 (no) Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
NO980471D0 (no) Benzensulfonamidderivater, fremstilling derav og terapautiske anvendelser derav
NO981537L (no) FremgangsmÕte for fremstilling av antimalariamedikamenter
FI973230A0 (fi) Uusi farmaseuttinen formulaatio
NO891574L (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
NO982755L (no) Kovalente lipid-fosfonokarboksylsyrederivater og deres anvendelse som antivirusmedikamenter
TR28699A (tr) Imidazopiridin türevlerinin hazirlanmasi icin yöntem.
FI940551A0 (fi) Menetelmä fenyylibentsamidijohdannaisten valmistamiseksi
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
DK568289D0 (da) 1-aminoalkyl-3-oxy-substituerede-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-oner, deres fremstilling og anvendelse som laegemidler
NO894707L (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application